The subject has a baseline corrected QT interval =<  ms
Patients with a prolonged corrected QT interval (QTc) interval (>=  ms)
Baseline corrected QT (QTc) <  ms
Baseline corrected QT (QTc) =<  ms
A baseline corrected QT interval of >  ms; patients with left bundle branch block that is deemed not clinically significant may be enrolled with corrected QT > 
Congenital long QT syndrome or a corrected QTc interval ?  ms at screening
Clinically significant electrocardiogram (ECG) abnormality, including a marked baseline prolonged QT/QTc ([QT interval/corrected QT interval], e.g., a repeated demonstration of a QTc interval >  ms)
Clinically significant electrocardiogram (ECG) abnormality, including a marked baseline prolonged QT/ corrected QT (QTc) ([QT interval/corrected QT interval], eg, a repeated demonstration of a QTc interval >  ms)
Long QT or prolonged QTc (> ms)
History of long QT syndrome or whose corrected QT(QTc) interval measured (Fridericia method) at screening is prolonged (> ms)
Subject has QT interval corrected (QTc) > ms (both males and females) at Screening (repeat values may be obtained during the period between Screening and admission to the study site).
Within two weeks prior to enrollment: Corrected QT (QTc) interval =<  ms
Subjects with a corrected QT (QTc) >  ms (QTc >  msec for subjects with a bundle branch block at baseline
Patients with a corrected QT (QTc) >  ms in the baseline electrocardiography (EKG)
Subjects with a corrected QT (QTc) >  ms (QTc >  msec for subjects with a bundle branch block at baseline)
Corrected QT (QTc) > ms at baseline (average of  determinations at  minute intervals)
Baseline prolongation of the rate-corrected QT interval (QTc; example, repeated demonstration of QTc interval >  millisecond [ms], or history of congenital long QT syndrome, or torsades de pointes).
Corrected QT interval ([QTc] Fridericia) >  ms
Clinically active cardiac disease, including prolonged corrected QT (QTc) interval >=  ms (i.e. >= grade )
Patients with baseline corrected QT (QTc) >  ms or patients with symptomatic bradycardia
Congenital QT syndrome, corrected QT (QTc) >  ms
Corrected QT (QTc) =<  ms
Corrected QT interval (QTc) >  ms at baseline
Corrected QT (QTc) interval =<  ms by electrocardiogram (EKG)
Prolongation of QT interval (QT)/corrected QT interval (QTc) (QTc interval >  ms) using the Fridericia method of QTc analysis
Patients with baseline corrected QT (QTc) >  ms or patients who are taking medications that prolong the QTc interval at the time of screening
The subject has a corrected QT interval (QTc) >  ms at screening or has a history of long QT syndrome
Baseline corrected QT interval (QTc) =<  ms
Averaged corrected QT interval (QTc) baseline in  electrocardiography (ECG)s at least  minutes apart of >=  ms
Corrected QT interval (QTc) greater than  ms at baseline
Subjects with heart-rate corrected QT (QTc) interval ? ms or other factors that increase the risk of QT prolongation or arrhythmic events.
Congenital long QT syndrome or a corrected QT interval (QTc) ? ms at Screening (unless secondary to pacemaker or bundle branch block).
Baseline corrected QT interval (QTc) <  ms
History of long QT syndrome or whose corrected QT interval (QTc) measured (Fridericia method) at screening is prolonged (>  ms).
Congenital long QT syndrome or a corrected QTc interval ? ms at the Screening visit.
Corrected QT interval (QTc) >  ms at baseline (average of  determinations at  minutes interval)
Patients with a baseline electrocardiography (ECG) demonstrating a corrected QT (QTc) >  ms
History of long QT syndrome or whose corrected QT interval (QTc) measured (Fridericia method) at screening is prolonged (>  ms). Individuals who screen fail due to this criterion are not eligible to be re-screened
Baseline prolongation of the rate-corrected QT interval (QTc; example, repeated demonstration of QTc interval > millisecond [ms], or history of congenital, long-QT syndrome, or torsades de pointes).
Clinically significant electrocardiogram (ECG) abnormality, including a marked baseline prolonged QT/corrected QT (QTc) ([QT interval/corrected QT interval], e.g., a repeated demonstration of a QTc interval >  ms), a family or personal history of long or short QT syndrome, Brugada syndrome or known history of QTc prolongation, or torsade de pointes (TdP)
Baseline screening corrected QT (QTc) <  ms is eligible
Corrected QT interval (QTc) =<  ms within  days before enrollment
Patients will be required to have a baseline electrocardiogram (EKG) prior to the start of treatment; patients with a corrected QT (QTc) >  millisecond (ms) are excluded from the study
Baseline corrected QT interval (QTc) =<  ms
Subject has Long corrected QT interval (QTc) Syndrome at Screening.
A baseline corrected QT interval of >  ms
Patients must have a corrected QT (QTc) interval <  ms on baseline electrocardiogram (EKG)
Patient must not have corrected QT (QTc) >  ms within  days before enrollment
Patients with a baseline corrected QT interval (QTc) >  ms
The subject has a baseline corrected QT interval <  within  days before randomization
For patients on mefloquine arm, a baseline electrocardiogram (EKG) without evidence of prolonged corrected QT (QTc) interval >  ms or clinically significant arrhythmia must be obtained within  days prior to registration
Mean corrected QT (QTc) >  ms at time of screening
Baseline corrected QT interval (QTc) =<  ms
Corrected QT interval (QTc) <  ms
Corrected QT interval (QTc) greater than  ms
History of long QT syndrome or whose corrected QT interval (QTc) measured (Fridericia method) at screening is prolonged (>  ms for males and females).
Corrected QT (QTc) interval =<  ms
Corrected QT (QTc) interval =<  ms
Pre-treatment corrected QT (QTc) interval of greater than  ms
Corrected QT interval (QTc) <  ms
Clinically significant electrocardiogram (ECG) abnormality, including a marked Baseline prolonged QT interval/corrected QT interval ([QT/QTc], example, a repeated demonstration of a QTc interval > millisecond [ms]).
The subject has a corrected QT interval (QTc) >  ms at screening or has a history of long QT syndrome
History of long QT syndrome or whose corrected QT interval (QTc) measured (Fridericia method) at screening is prolonged (>  ms for males and >  ms for females). Individuals who screen-fail due to this criterion are not eligible to be re-screened
Corrected QT (QTc) interval =<  ms
Baseline corrected QT interval (QTc) >  ms
Correct QT (QTc) longer than  ms
Corrected QT (QTc) =<  ms
Corrected QT (QTc) interval =<  ms
Clinically significant electrocardiogram (ECG) abnormality, including a marked baseline prolonged QT/QTc ([QT interval/corrected QT interval], e.g., a repeated demonstration of a QTc interval >  ms)
EXCLUSION CRITERIA FOR CROSSOVER THERAPY: Clinically significant electrocardiogram (ECG) abnormality, including a marked baseline prolonged QT/QTc ([QT interval/corrected QT interval], e.g., a repeated demonstration of a QTc interval >  ms)
PATIENTS: History of prolonged corrected QT (QTc) interval (>  ms)
Patients with corrected QT (QTc) interval greater than  ms
Patients must not have baseline corrected QT (QTc) interval >=  ms
Patients with familial short QT syndrome or with corrected QT (QTc) interval =<  ms
Corrected QT interval (QTc) >  ms per Fridericias correction
Patients with corrected QT (QTc) interval > . seconds
Corrected QT (QTc) (Fredericias formula) <  ms
Prolongation of corrected QT interval (QTc) to > ms as demonstrated by a repeated electrocardiogram (ECG) or a clinically significant ECG abnormality, including a marked prolonged QT/QTc interval (eg, a repeated demonstration of a QTc interval > ms).
Congenital long QT syndrome or a corrected QTc interval of ? ms at the Screening visit.
